RU97116007A - PHARMACEUTICAL COMPOSITION WITH ADJUSTABLE SHIPPING FOR ORAL ADMINISTRATION, CONTAINING AS AN ACTIVE INGREDIENT NIFEDIPIN, THE METHOD OF ITS RECEIVING - Google Patents
PHARMACEUTICAL COMPOSITION WITH ADJUSTABLE SHIPPING FOR ORAL ADMINISTRATION, CONTAINING AS AN ACTIVE INGREDIENT NIFEDIPIN, THE METHOD OF ITS RECEIVINGInfo
- Publication number
- RU97116007A RU97116007A RU97116007/14A RU97116007A RU97116007A RU 97116007 A RU97116007 A RU 97116007A RU 97116007/14 A RU97116007/14 A RU 97116007/14A RU 97116007 A RU97116007 A RU 97116007A RU 97116007 A RU97116007 A RU 97116007A
- Authority
- RU
- Russia
- Prior art keywords
- nifedipine
- composition according
- precipitation
- oral administration
- pharmaceutical composition
- Prior art date
Links
- HYIMSNHJOBLJNT-UHFFFAOYSA-N Nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 title claims 10
- 239000008194 pharmaceutical composition Substances 0.000 title claims 3
- 239000004480 active ingredient Substances 0.000 title 1
- 229960001597 Nifedipine Drugs 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- 238000000975 co-precipitation Methods 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 4
- 239000001913 cellulose Substances 0.000 claims 3
- 229920002678 cellulose Polymers 0.000 claims 3
- 238000004090 dissolution Methods 0.000 claims 3
- 239000008187 granular material Substances 0.000 claims 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 3
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 claims 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 2
- 229940096529 carboxypolymethylene Drugs 0.000 claims 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 2
- 239000008101 lactose Substances 0.000 claims 2
- 230000001681 protective Effects 0.000 claims 2
- 230000000979 retarding Effects 0.000 claims 2
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 claims 1
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 229940105329 Carboxymethylcellulose Drugs 0.000 claims 1
- DOIRQSBPFJWKBE-UHFFFAOYSA-N Dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 claims 1
- FLKPEMZONWLCSK-UHFFFAOYSA-N Diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims 1
- 229940031574 HYDROXYMETHYL CELLULOSE Drugs 0.000 claims 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 claims 1
- 229920001800 Shellac Polymers 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- URAYPUMNDPQOKB-UHFFFAOYSA-N Triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims 1
- 229960002622 Triacetin Drugs 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 230000003111 delayed Effects 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000001087 glyceryl triacetate Substances 0.000 claims 1
- 235000013773 glyceryl triacetate Nutrition 0.000 claims 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000012188 paraffin wax Substances 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000004208 shellac Substances 0.000 claims 1
- 229940113147 shellac Drugs 0.000 claims 1
- 235000013874 shellac Nutrition 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
Claims (9)
аморфный продукт соосаждения нифедипина и поливинилпирролидона;
гидрофильное производное целлюлозы в количестве, варьирурующем по массе от 0,1 до 6 раз относительно количества нифедипина;
карбоксиполиметилен и лактозу в количестве, варьирующем по массе от 0,1 до 5 раз относительно количества нифедипина и
защитную или задерживающую растворение поверхностную оболочку.1. A controlled release pharmaceutical composition for oral administration containing nifedipine as an active substance, characterized in that it comprises
amorphous product of co-precipitation of nifedipine and polyvinylpyrrolidone;
hydrophilic cellulose derivative in an amount varying by weight from 0.1 to 6 times relative to the amount of nifedipine;
carboxypolymethylene and lactose in an amount varying by weight from 0.1 to 5 times relative to the amount of nifedipine and
protective or delayed dissolution surface shell.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI96A001983 | 1996-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU97116007A true RU97116007A (en) | 1999-07-20 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2518882B2 (en) | Coating film and composition prepared therefrom | |
EP0142561B1 (en) | Long-acting nifedipine preparation | |
AU606149B2 (en) | Pharmaceutical formulations | |
US6348490B1 (en) | Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability | |
KR100350940B1 (en) | Stabilized pharmaceutical composition containing bupropion | |
FI92903B (en) | Method of preparation of a long-acting pharmaceutical preparation | |
EP0324981B1 (en) | New galenic formulations with programmed release | |
US4814175A (en) | Nifedipine combination preparation | |
US4647599A (en) | Sustained release pharmaceutical tablets and process for the preparation thereof | |
US20020102300A1 (en) | Pharmaceuticals formulation | |
DE642785T1 (en) | Heterodisperse hydrogel systems for the delayed release of insoluble drugs. | |
EA006103B1 (en) | Paracetamol pharmaceutical composition | |
SE509029C2 (en) | Long-acting diclofenac sodium preparations | |
JPH05246849A (en) | Medicinal composition | |
AU719075B2 (en) | Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance | |
AU2009315449B2 (en) | Novel method for preparing granulates of active principles, and granulates obtained thereof | |
AU1543702A (en) | Multiparticulate formulations of lithium salts for oral administration suitable for-a-day administration | |
RU97116007A (en) | PHARMACEUTICAL COMPOSITION WITH ADJUSTABLE SHIPPING FOR ORAL ADMINISTRATION, CONTAINING AS AN ACTIVE INGREDIENT NIFEDIPIN, THE METHOD OF ITS RECEIVING | |
CN102293759A (en) | Dextral ibuprofen sustained release tablet preparation and preparation method thereof | |
JP2004522780A5 (en) | ||
RU97101469A (en) | METHOD FOR PRODUCING CARBAMAZEPINE DOSAGE FORM | |
US20070042037A1 (en) | Pharmaceutical composition containing levodopa and carbidopa | |
CN102970980A (en) | Controlled release levetiracetam formulations | |
JP2621259B2 (en) | Long-acting formulation | |
JPS63243030A (en) | Sustained release cephradine pharmaceutical |